420 with CNW — Research into Medical Benefits of Marijuana Is Growing

Decades of federal prohibition, intense policing and harsh sentencing made it virtually impossible for researchers to study the possible effects and risks of cannabis consumption. But over the past 20 years or so, loosening marijuana policies across the country have made it possible for scientists to finally study cannabis. Anecdotal reports coupled with initial studies have revealed that cannabis has plenty of medical potential, leading to a slew of states legalizing medical cannabis.

More than 25 years after California first legalized medical cannabis, researchers are still delving into the controversial plant. There’s still a lot that we don’t know about cannabis, including how long-term consumption can affect users; this is primarily due to restrictions placed on cannabis research by the federal government.

Most of our scientific data on cannabis comes from a handful of studies that were mostly carried out by pharmaceutical companies, universities and other entities, with a significant percentage of the funding for these studies coming from the National Institutes of Health and the National Institute on Drug Abuse.

In recent months, however, the U.S. Drug Enforcement Administration (DEA) has expanded the number of entities that are federally allowed to research cannabis from one to six. The DEA has also issued cannabis research licenses to entities interested in delving deeper into marijuana’s properties and effects and has even awarded licenses to companies with state-level marijuana retail licenses, including MedPharma Holdings in Colorado.

The cannabis research field has also seen a slight increase in federal funding opportunities, with one Connecticut-based firm, CT Pharma,  managing to snag federal approval for a partnership that would see it supply cannabis to Yale University for research purposes. The segment is also expected to see an infusion of federal funding due to a provision in last year’s $1 trillion federal infrastructure bill, which allows researchers to use cannabis from state-licensed retail businesses in their studies.

Surprisingly, plenty of federally sanctioned marijuana growers and researchers say that the Food and Drug Administration (FDA) has been quite supportive. In a prior interview with MJBizDaily, MedPharma CEO Albert Gutierrez said that working with the DEA has been quite good, stating that while the federal agencies can be slow, they are responsive. Scottsdale Research Institute’s Dr. Sue Sisley also noted the company’s great working relationship with the DEA, saying that the agency has been a collaborative supporter in the decade and a half since it began working with the institute.

Attitudes in the scientific, medical and pharmaceutical industries are shifting in favor of cannabis research, with millions of dollars being invested in medical marijuana research. There are an increasing number of studies looking into cannabis’ impact on ailments such as sleep problems, brain inflammation, opiate replacement and pain management. We can expect to see even more cannabis research in the coming years if lawmakers pass federal cannabis legislation and remove the existing restrictions on research.

As those restrictions are eased, it could get a little easier for sector players such as American Cannabis Partners to conduct the requisite research in the course of coming up with innovative products to suit the changing dynamics of the marijuana market.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Archives

Select A Month
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • July 2016
  • Official NewsWire Relationships

    Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

    CannabisNewsWire Currently Accepts

    Bitcoin

    Bitcoin

    Bitcoin Cash

    Bitcoin Cash

    Doge Coin

    Dogecoin

    Ethereum

    Ethereum

    Litecoin

    Litecoin

    USD Coin

    USD Coin

    Contact us: 512.354.7000